WO2017164649A3 - Dispositif et procédé de diagnostic in vitro - Google Patents

Dispositif et procédé de diagnostic in vitro Download PDF

Info

Publication number
WO2017164649A3
WO2017164649A3 PCT/KR2017/003087 KR2017003087W WO2017164649A3 WO 2017164649 A3 WO2017164649 A3 WO 2017164649A3 KR 2017003087 W KR2017003087 W KR 2017003087W WO 2017164649 A3 WO2017164649 A3 WO 2017164649A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomaterial
light
diagnostic device
vitro diagnostic
unit
Prior art date
Application number
PCT/KR2017/003087
Other languages
English (en)
Korean (ko)
Other versions
WO2017164649A2 (fr
Inventor
김영수
장제영
하춘화
Original Assignee
주식회사 비바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 비바이오 filed Critical 주식회사 비바이오
Publication of WO2017164649A2 publication Critical patent/WO2017164649A2/fr
Publication of WO2017164649A3 publication Critical patent/WO2017164649A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/42—Photometry, e.g. photographic exposure meter using electric radiation detectors
    • G01J1/44—Electric circuits
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
    • G01N33/48792—Data management, e.g. communication with processing unit
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J1/00—Photometry, e.g. photographic exposure meter
    • G01J1/42—Photometry, e.g. photographic exposure meter using electric radiation detectors
    • G01J1/44—Electric circuits
    • G01J2001/4446—Type of detector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ecology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Databases & Information Systems (AREA)
  • Human Computer Interaction (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un dispositif et un procédé de diagnostic in vitro pour diagnostiquer la santé d'un utilisateur en analysant, par le biais de la réflectivité de la lumière, un état de réaction d'un antigène et d'un anticorps artificiel. Selon un mode de réalisation de la présente invention, le dispositif de diagnostic in vitro comprend : une unité de réaction comprenant un anticorps artificiel réagissant avec un antigène d'un biomatériau lorsque le biomatériau d'un utilisateur est injecté en son sein; une unité d'émission de lumière destinée à émettre de la lumière au niveau du biomatériau injecté dans l'unité de réaction; une unité de réception de lumière destinée à recevoir la lumière réfléchie à travers le biomatériau; et une unité de commande destinée à confirmer la concentration du biomatériau en analysant la lumière reçue dans l'unité de réception de lumière, et à confirmer les informations de diagnostic correspondant à la concentration du biomatériau.
PCT/KR2017/003087 2016-03-22 2017-03-22 Dispositif et procédé de diagnostic in vitro WO2017164649A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0033846 2016-03-22
KR1020160033846A KR20170109800A (ko) 2016-03-22 2016-03-22 체외진단 장치 및 방법

Publications (2)

Publication Number Publication Date
WO2017164649A2 WO2017164649A2 (fr) 2017-09-28
WO2017164649A3 true WO2017164649A3 (fr) 2018-09-07

Family

ID=59900421

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/003087 WO2017164649A2 (fr) 2016-03-22 2017-03-22 Dispositif et procédé de diagnostic in vitro

Country Status (2)

Country Link
KR (1) KR20170109800A (fr)
WO (1) WO2017164649A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323373B1 (ko) * 2011-07-26 2013-10-29 김수동 뇨, 혈액, 타액, 생체분비물 등의 체액으로 질병을 진단할 수 있는 휴대용 디지털멀티리더기
WO2016019701A1 (fr) * 2014-08-05 2016-02-11 Sanwa Biotech Ltd Système de diagnostic sur site et procédé correspondant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323373B1 (ko) * 2011-07-26 2013-10-29 김수동 뇨, 혈액, 타액, 생체분비물 등의 체액으로 질병을 진단할 수 있는 휴대용 디지털멀티리더기
WO2016019701A1 (fr) * 2014-08-05 2016-02-11 Sanwa Biotech Ltd Système de diagnostic sur site et procédé correspondant

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HWANG, DA EUN ET AL.: "Innopolis Foundation Promotional Video", (BT 05) ARTIFICIAL ANTIBODY REPEBODY-BASED HIGHLY SENSITIVE IMMUNOASSAY (2015), Retrieved from the Internet <URL:https://www.innopolis.or.kr/sub0504/articles/view/tableid/media/page/7> *
LEE ET AL.: "(OP15)Module-based Design of the Repebody Scaffold with High Affinity for a Target Molecule", THE KOREAN SOCIETY FOR BIOTECHNOLOGY AND BIOENGINEERING, 2012, pages 140 *
LEE ET AL.: "Design of a Binding Scaffold Based on Variable Lymphocyte Receptors of lawless Vertebrates by Module Engineering", PNAS, vol. 109, no. 9, 2012, pages 3299 - 3304, XP055540940 *
PYO ET AL.: "Synthesis and Evaluation of 64Cu Labeled Repebody for EGFR-mediated Cancer Imaging in Small Animals", JOURNAL OF NUCLEAR MEDICINE, vol. 56, no. 3, 2015, pages 172 *

Also Published As

Publication number Publication date
KR20170109800A (ko) 2017-10-10
WO2017164649A2 (fr) 2017-09-28

Similar Documents

Publication Publication Date Title
CY1123005T1 (el) Κατασκευασματα αντισωματος για cdh19 και cd3
MX360210B (es) Dispositivo y metodo para obtener informacion de signos vitales de un ser vivo.
EP2375137A3 (fr) Module d&#39;éclairage et appareil d&#39;éclairage l&#39;incluant
EP2490008A3 (fr) Procédé et appareil de mesure de pH de solutions
IN2015DN03125A (fr)
ES2653664T3 (es) Generación y caracterización de anticuerpos terapéuticos obtenidos mediante HuCal GOLD completamente humanos específicos de CD38 humano
JP2019503827A5 (fr)
EP2402736A3 (fr) Capteur de gaz &#34;Cavity-Ring-Down&#34; à longueur d&#39;onde variable
WO2005080985A3 (fr) Methodes et compositions permettant de detecter et de traiter des maladies auto-immunes
ATE416667T1 (de) Verfahren und vorrichtung zur verfolgung von augenbewegungen
EA201290961A1 (ru) Способы применения растворимого cd24 для лечения ревматоидного артрита
ITPD20030264A1 (it) Metodo di diagnosi altamente specifico per neoplasie
WO2008076353A3 (fr) Spectrophotomètre optique
AU2018249796A1 (en) Antibody Fc variants for improving blood half-life
WO2011088128A3 (fr) Procédés de détection et d&#39;analyse de biomolécules et de complexes de biomolécules (bmc) et leur utilisation pour la recherche et le diagnostic médical
WO2017164649A3 (fr) Dispositif et procédé de diagnostic in vitro
EP2813927A3 (fr) Commande adaptative de source de lumière de système optique intégrant le toucher et le survol
RU2009100497A (ru) Способ определения времени реакции человека на движущийся по направлению к нему объект
GB0706558D0 (en) Diagnostic assay
WO2010053772A3 (fr) Antigènes associés à une maladie et leurs procédés d&#39;utilisation
UA111405U (uk) Спосіб діагностики розвитку остеопорозу
TW200720440A (en) Method
UA108291U (uk) Спосіб діагностики розвитку остеопорозу
UA111011U (uk) Спосіб діагностики розвитку остеопорозу
UA108294U (uk) Спосіб діагностики розвитку остеопорозу

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17770619

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17770619

Country of ref document: EP

Kind code of ref document: A2